Skip to main content
(09) 535 7218 (Mon-Fri, 8.30-4.30)

Counties Manukau Zoledronate Infusion Subsidy

Service Information

Health NZ (Counties Manukau) will subsidise the administration of Zoledronate upon application by their GP, for patients who fulfil specified criteria.  

Zoledronate can be administered within the referring GP's clinic, or at an Approved Infusion Centre, upon referral.

Most patients can be managed with 3 infusions 18 months apart. Where bone density is very low, or the patient suffers a subsequent low-trauma/fragility fracture, the infusions may be indicated 12 monthly. Where bone density fails to improve sufficiently, additional infusions may be indicated.

Criteria

Confirm patient meets POAC funding criteria below.  

Funding criteria:

  • Patient resident in Counties Manukau** catchment area, AND

  • Patients eGFR >35, AND

  • Patient holds a CSC card

AND

  • Recommended by hospital specialist, including previous administration as an inpatient or outpatient, OR

  • Serious adverse reaction to Alendronate, OR

  • Unsuitable for use of oral medication

** For patients who reside in Auckland or Waitemata refer to:  Zoledronic Acid Infusion Regional HealthPathway

Funding and Claiming

1. Complete referral to a registered infusion centre using the online form here, OR proceed with infusion (refer to checklist)

2. Submit referral and claim via the POAC PMS claiming system using the Zoledronate Infusion code.

 

This product has been added to your cart

CHECKOUT